Search Browse Earnings

Sunshine Biopharma Inc.

Nasdaq:SBFMNasdaq:SBFMW

Pharmaceutical Preparations·FORT LAUDERDALE, FL

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Sunshine Biopharma Inc. — SlamSEC

Revenue

$24.1M

+454.4% YoY

FY 2024

Adj. EBITDA

-$4.6M

-19.2% margin

FY 2024

Net Income

-$4.5M

-18.7% margin

FY 2024

EPS (Diluted)

-$351.36

FY 2024

Stock Price

$1.11

+0.0%

2026-03-09

52W Range

$1.05 – $3.90

P/E Ratio

-0.0x

Market Cap

$5.4M

Cash

$2.0M

FY 2022

Total Debt

$2.7M

FY 2022

Net Debt

$675,287

FY 2022

Enterprise Value

$6.1M

Debt / EBITDA

-0.1x

FY 2024

EV / EBITDA

-1.3x

Employees

—

CEO

Slilaty Steve N.

CFO

Sebaaly Camille